Gerald and Patricia Turpanjian School of Public Health, American University of Armenia, Room 410W, Baghramyan 40, 0019, Yerevan, Armenia.
Toronto Health Economics and Technology Assessment (THETA) Collaborative, University of Toronto, Toronto, ON, Canada.
Int J Public Health. 2020 Jan;65(1):37-43. doi: 10.1007/s00038-019-01277-2. Epub 2019 Jun 25.
This study aimed to investigate the impact of diabetes on the treatment outcomes among pulmonary TB patients in Yerevan, Armenia.
We utilized a cohort study design that included TB patients with diabetes and TB patients without diabetes. The data collection was conducted in the National Tuberculosis Control Center, eight tuberculosis outpatient centers and the 'Prisoners' Hospital' in Yerevan, Armenia. Data were collected from an existing national TB database and patients medical records. Multivariable logistic regressions were conducted to construct the final model and test the associations.
The final sample included 621 patients 5.8% of whom had diabetes. The odds of having treatment failure was 8.99 times higher among TB patients with diabetes (95% confidence interval 2.51-32.23) compared to TB patients without diabetes after adjusting for weight and sputum smear status.
Diabetes comorbidity had a negative effect on TB treatment outcomes. Countries with a high burden of both TB and diabetes need to develop mechanisms for active screening for diabetes among patients with TB and address their treatment needs carefully.
本研究旨在探讨亚美尼亚埃里温的糖尿病对肺结核患者治疗结果的影响。
我们采用了队列研究设计,纳入了患有糖尿病的肺结核患者和没有糖尿病的肺结核患者。数据收集在亚美尼亚埃里温的国家结核病控制中心、八个肺结核门诊中心和“囚犯医院”进行。数据来自现有的国家结核病数据库和患者病历。多变量逻辑回归用于构建最终模型并检验关联。
最终样本包括 621 名患者,其中 5.8%患有糖尿病。调整体重和痰涂片状态后,患有糖尿病的肺结核患者的治疗失败风险比没有糖尿病的肺结核患者高 8.99 倍(95%置信区间 2.51-32.23)。
糖尿病合并症对结核病治疗结果有负面影响。结核病和糖尿病负担高的国家需要制定机制,在结核病患者中积极筛查糖尿病,并认真解决他们的治疗需求。